Telemedicine proven effective for dementia care, WHO study finds
NEW YORK, UNITED STATES — Telemedicine is emerging as a powerful tool for dementia care, with new findings from the World Health Organization (WHO) showing that remote healthcare significantly improves mental well-being, cognitive function, and quality of life for patients, according to a report from Medscape.
Telehealth boosts mental health, reduces caregiver burden
According to the WHO researchers, telemedicine initiatives such as video calls, phone consultations, and virtual cognitive therapies provide meaningful relief for patients and caregivers alike.
The study reported reductions in depression, anxiety, and stress, while indoor falls decreased by as much as 64%.
With dementia cases in the European Union expected to rise from 9.1 million to 14.3 million by 2050, remote care is poised to play a crucial role in supporting the region’s healthcare systems.
David Novillo-Ortiz, PhD, unit head and regional adviser of data, AI, and digital health at the WHO’s Regional Office for Europe, emphasized the long-term potential of telemedicine.
“The study suggests that with proper investment in training, connectivity, and data governance, wider adoption could become standard practice within the next few years,” he said, adding that these improvements would support the UN Decade of Healthy Ageing (2021–2030).
The review analyzed 91 studies and found that 80%–90% of participants were “satisfied” with telehealth solutions. Patients described telemedicine as “convenient” and “accessible” and reported benefits including reduced “travel-related burden” and “enhanced user support.”
Technologies such as videoconferencing and online peer-support platforms were especially effective in easing loneliness, with 67% of caregivers reporting notable reductions in social isolation.
For outsourcing providers, particularly those specializing in healthcare business process outsourcing (BPO), these findings reflect the growing demand for remote patient support, telehealth coordination, digital triage, and AI-backed clinical assistance.
As telemedicine scales across borders, global service providers can support hospitals and clinicians with 24/7 patient monitoring, technical support, and data management.
Challenges, tailored solutions for telemedicine in dementia
Despite the promising results, telemedicine is “not equally effective for everyone,” Novillo-Ortiz cautioned.
While patients with mild-to-moderate dementia benefit most, individuals with advanced impairment or limited caregiver support may struggle to engage with digital platforms.
In these cases, hybrid or in-person care remains crucial.
Experts also stressed the need for personalized telehealth solutions. Giovanni B. Frisoni, MD, professor of clinical neurosciences at the University of Geneva, said that behavioral symptoms often respond well to online interventions.
Sharing his experience, he noted that some patients improved through “group chats that allowed text and videos to be shared across multiple actors,” helping clinicians fine-tune medication more frequently.
Scalability, however, depends on training, infrastructure, and technical support—areas where outsourcing and offshoring can fill significant gaps.
“These interventions can be scaled effectively with minimal training when users have access to connectivity and devices,” Novillo-Ortiz said, highlighting the need for global collaboration.
The review also revealed that most existing studies were rated “low” or “critically low” in quality, underscoring the need for stronger research.
As Frisoni summarized, “The efficacy of telemedicine approaches should be discussed on a problem-by-problem basis… Specific solutions should be developed and tested.”
As global healthcare systems seek efficiency and continuity of care, the outsourcing sector stands to play a major role in expanding telehealth services, particularly as demand grows for remote dementia care across regions and income levels.
